3
Announcements
Trials
Browse
Landscape
Status
No longer available
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
12
Observational
1
Expanded_access
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Lung Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Adenocarcinoma of Lung
1
Interventions
3-Iodobenzylguanidine
2
Gemcitabine
2
Powders
2
Suspensions
2
balstilimab
2
leronlimab
2
ruxolitinib
2
talquetamab
2
Abiraterone Acetate
1
Alpelisib
1
Androgen Antagonists
1
Asparaginase
1
Bone Marrow Transplantation
1
Capecitabine
1
Cyclophosphamide
1
Docetaxel
1
Eflornithine
1
FANG vaccine
1
HMPL-013
1
Hydrocortisone
1
Immunotherapy, Adoptive
1
Insulin Infusion Systems
1
LY3023414
1
Magnetic Resonance Spectroscopy
1
Methionine
1
Nivolumab
1
Paclitaxel
1
Peripheral Blood Stem Cell Transplantation
1
Prednisolone
1
Prednisone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Expanded_access
×
capmatinib
×
1 year
×
Clear all
NCT04741789
2026-03-16
Managed Access Programs for INC280, Capmatinib
Novartis
No longer available